Macular pigment optical density following lutein scleral iontophoresis in intermediate age-related macular degeneration: A six-month pilot study
British Journal of Ophthalmology · 2026
DOI: 10.1136/bjo-2025-328403 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2026. Verfasst von Rodolfo Mastropasqua und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Imaging and Clinical Sciences, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy. Hauptthemen laut MEDLINE: Lutein, Macular Degeneration, Macular Pigment, Iontophoresis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Purpose
To evaluate the effects of scleral iontophoresis lutein delivery on macular pigment optical density (MPOD), retinal anatomy and function in patients with intermediate age-related macular degeneration (iAMD).
Methods
This prospective pilot study included 15 phakic eyes from patients with iAMD. All participants underwent a single session of trans-scleral iontophoresis with a liposomal lutein formulation. MPOD, central macular thickness (CMT), choroidal vascularity index (CVI) and retinal sensitivity (RS) were assessed at baseline (T0), and at 1 month (T1), 3 months (T2) and 6 months (T3).
Results
MPOD showed a significant overall change across time points (χ²=11.01, p=0.012), with significant differences between T1 and T3 (p=0.006) and T2 and T3 (p=0.018). CMT significantly decreased at T3 compared with earlier visits (p≤0.002). RS declined at early time points (T1 and T2 vs T0; p=0.027 and p=0.002, respectively), while CVI exhibited modest reductions by T2 and T3 (p=0.021 and p=0.017). A significant inverse correlation was found between ΔMPOD and ΔRS at T2–T0 (ρ=−0.520, p=0.035). Best-corrected visual acuity remained stable across all visits.
Conclusions
The inverse correlation between MPOD change and RS decline at 3 months raises the possibility that early augmentation of MP may provide a protective functional effect. These data support the short-term feasibility of scleral iontophoresis for targeted lutein delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosciences, Imaging and Clinical Sciences, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy.
- Ophthalmology Clinic, SS Annunziata Hospital, Chieti, Italy.
- Department of Neurosciences, Imaging and Clinical Sciences, University "G. d'Annunzio" Chieti-Pescara, Chieti, Italy alberto.quarta.96@gmail.com.
- Department of Medical, Oral and Biotechnological Sciences, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy.
Zitieren
APA
Mastropasqua, R., Quarta, A., Passamonti, M., Lorenzi, C., Ruggeri, M. L., Gironi, M., Persavalli, C., Belloni Baroni, L., De Santis Ciacci, C., Aloia, R., Della Penna, N., Toto, L., Carpineto, P., & Mastropasqua, L. (2026). Macular pigment optical density following lutein scleral iontophoresis in intermediate age-related macular degeneration: A six-month pilot study. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2025-328403
Vancouver
Mastropasqua R, Quarta A, Passamonti M, Lorenzi C, Ruggeri ML, Gironi M, et al. Macular pigment optical density following lutein scleral iontophoresis in intermediate age-related macular degeneration: A six-month pilot study. British Journal of Ophthalmology. 2026. doi:10.1136/bjo-2025-328403
BibTeX
@article{Mastropasqua2026,
author = {Mastropasqua, Rodolfo and Quarta, Alberto and Passamonti, Marzia and Lorenzi, Carolina and Ruggeri, Maria Ludovica and Gironi, Matteo and Persavalli, Cesare and Belloni Baroni, Luca and De Santis Ciacci, Corina and Aloia, Raffaella and Della Penna, Nicola and Toto, Lisa and Carpineto, Paolo and Mastropasqua, Leonardo},
title = {Macular pigment optical density following lutein scleral iontophoresis in intermediate age-related macular degeneration: A six-month pilot study},
journal = {British Journal of Ophthalmology},
year = {2026},
doi = {10.1136/bjo-2025-328403}
}
EUVIMED